Goat, we have predicted nothing on the Board
MSK? No chance. No one saw it coming, and no one here predicted it.
AZN? No chance. No one saw it coming, and no one here predicted it.
NCCN? No chance. No one saw it coming, and no one here predicted it.
See a trend?
Garnick clearly will have input into the BLA, but since it's a bear to put together, obviously he will guide the team who does it. That's what a seasoned supervisor does.
Your predictions have a certainly about them. They will all be WRONG.
Is Bavi Phase III a slam-dunk? Well, if you've lived long enough, you learn that nothing in life is a slam-dunk. But I like my odds. I like them even more now that MSK, AZN, and NCCN are on board. Clearly they see something you don't. Please, don't feel offended if I go with them.
Bears have pontificated here for years, brow-beating us for "external" validation for Bavi. "Only UTSW agrees, and they don't count." Well, when we get external validation of the MOA, when the number of literature citations continues to grow (1500+ papers), when researchers in other universities cite Bavi as a universal checkpoint inhibitor, when top-notch research labs want access to Bavi, what do we get? Well, more FUD.
I know the ol' Volgoat is in there somewhere. Hope to read him soon.
Regards,
Joe "Six-Pack"
Market Data 
Markets 
AI
